Percutaneous absorption of topically-applied antiandrogens: an assessment with three independent methods.
D000042:Absorption; D000287:Administration, Topical; D000726:Androgen Antagonists / Q000008:administration & dosage* / Q000378:metabolism; D000818:Animals; D001345:Autoradiography; D001682:Biological Availability; D003534:Cyproterone / Q000378:metabolism; D007700:Kinetics; D008655:Mesterolone / Q000031:analogs & derivatives / Q000378:metabolism; D008722:Methods; D011817:Rabbits; D051381:Rats; D012867:Skin / Q000378:metabolism*
D000726:Androgen Antagonists; D008655:Mesterolone; C041614:17-propylmesterolone; D003534:Cyproterone